Dexcom | DXCM - Interest Expense On Debt

Stock Price
61.57
Daily Change
-1.13 -1.80%
Monthly
-7.88%
Yearly
-14.08%
Q2 Forecast
60.25

Dexcom reported $4.7M in Interest Expense on Debt for its fiscal quarter ending in September of 2025.





Interest Expense On Debt Change Date
Abbott USD 68M 26M Mar/2026
Align Technology USD 2M 660K Mar/2023
AtriCure USD 1.33M 17K Sep/2025
Avanos Medical USD 1.9M 100K Dec/2025
Baxter International USD 58M 14M Sep/2025
Becton, Dickinson and Co. USD 153M 2M Dec/2025
Boston Scientific USD 90M 0 Mar/2026
Cooper Companies USD 22.4M 2M Dec/2025
Dexcom USD 4.7M 0 Sep/2025
Edwards Lifesciences USD 35.9M 2.7M Dec/2025
Globus Medical USD 17K 5.1B Dec/2025
Inogen 1.03M 384K Mar/2025
Insulet USD 9.2M 2.2M Dec/2025
Integra LifeSciences USD 23.67M 953K Dec/2025
J&J USD 43M 25M Mar/2026
Masimo USD 7.5M 1.3M Dec/2025
Medtronic USD 181M 0 Dec/2025
Merit Medical Systems USD 6.36M 390K Dec/2025
Roche Holding CHF 304M 7.5M Jun/2025
Solventum Corp USD 51M 13.92B Dec/2025
Stryker USD 157M 46.17B Sep/2025
Tandem Diabetes Care USD 2.07M 872.58M Dec/2025
Teleflex USD 28.15M 3.69M Dec/2025
West Pharmaceutical Services USD 1.9M 1.7M Mar/2026
Zimmer Biomet Holdings USD 71.9M 3.5M Dec/2025